ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SHP Shire

4,690.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shire LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4,690.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Shire plc Total Voting Rights

01/12/2016 12:00pm

UK Regulatory


 
TIDMSHP 
 
Total Voting Rights 
 
December 1, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in 
accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") 
Disclosure Rules and Transparency Rules, notifies the market of the following: 
 
As at November 30, 2016, the Company's issued ordinary share capital comprised 
904,011,842 ordinary shares of 5 pence each with voting rights and a further 
7,971,461 ordinary shares held in treasury. 
 
Therefore, the total number of voting rights in the Company is 904,011,842. 
This is the figure which should be used by shareholders as the denominator for 
the calculations by which they will determine if they are required to notify 
their interest in, or a change to their interest in, the Company under the 
FCA's Disclosure Rules and Transparency Rules. 
 
Sarah Rixon 
Company Secretarial Assistant 
 
For further information please contact: 
 
Investor Relations 
 
Sarah Elton-Farr                seltonfarr@shire.com       +44 1256 894157 
 
Ian Karp                        ikarp@shire.com            +1 781 482 9018 
 
Robert Coates                   rcoates@shire.com          +44 1256 894874 
 
NOTES TO EDITORS 
 
About Shire 
 
Shire is the leading global biotechnology company focused on serving people 
with rare diseases and other highly specialized conditions. We strive to 
develop best-in-class products, many of which are available in more than 100 
countries, across core therapeutic areas including Hematology, Immunology, 
Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / 
Internal Medicine / Endocrine and Hereditary Angioedema; and a growing 
franchise in Oncology. 
 
Our employees come to work every day with a shared mission: to develop and 
deliver breakthrough therapies for the hundreds of millions of people in the 
world affected by rare diseases and other high-need conditions, and who lack 
effective therapies to live their lives to the fullest. 
 
www.shire.com 
 
 
 
END 
 

(END) Dow Jones Newswires

December 01, 2016 07:00 ET (12:00 GMT)

1 Year Shire Chart

1 Year Shire Chart

1 Month Shire Chart

1 Month Shire Chart

Your Recent History

Delayed Upgrade Clock